Literature DB >> 7583681

Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration.

A Brun1, X Liu, C Erikson.   

Abstract

Changes in density of synapses and astrocytes in the molecular layer of the frontal and parietal cortex were compared in Alzheimer's disease (AD) and frontal lobe degeneration of non-Alzheimer type (FLD). The investigation was limited to the molecular layer because it is possible in this part of the cortex to measure changes in synapses and astrocytes without contamination by nerve cell body changes. In the frontal pole synapse density declined by 40% in both FLD and AD whereas in the parietal area there was a 50% decrease in synapse density in AD but no significant change in FLD. Number of astrocytes showed an inverse relationship to synapse density. There was a significant increase in astrocytes in the frontal cortex in both FLD and AD but in the parietal cortex such an increase was seen only in AD. These results confirm previous reports of synapse loss in AD and demonstrate a similar loss in FLD in the frontal, but not parietal cortex. The findings underscore the regional pattern changes of FLD, previously shown for other parameters, and its difference from that of AD. We propose that these changes in molecular layer may be representative of the pathology (and the functional deficit) within the underlying cortical layers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583681     DOI: 10.1006/neur.1995.0021

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  29 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Synapse loss in dementias.

Authors:  Ryan Clare; Victoria G King; Martin Wirenfeldt; Harry V Vinters
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

Review 3.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

Review 4.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

Review 5.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 6.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

7.  Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation.

Authors:  R K Lee; W Araki; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 8.  Selective functional, regional, and neuronal vulnerability in frontotemporal dementia.

Authors:  William W Seeley
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

9.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

10.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.